Public health and infectious disease experts said they were surprised and confused about the move, and questioned why the HHS did not offer any reasoning for its decision.

The agency’s decision to clear Moderna’s shot for use in certain younger adults is a much-needed win for a company that’s ...

Novavax, Inc. faces profitability challenges despite a promising tech platform, with uncertain revenue streams. Click for my ...

This story is from the next print edition of MIT Technology Review, which explores power—who has it, and who wants it. It’s ...

A new article in the Journal of the American Medical Association said the FDA will implement AI into multiple processes.

In case you haven't had enough artificial intelligence, the US Food and Drug Administration is now outsourcing its oversight ...

Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and ...

The FDA’s accelerated approval pathway plays a vital role, and scrapping it or reversing course on already-approved therapies ...

When two of medicine’s most outspoken reformers publish a roadmap for the FDA, you expect at least coherence. Instead, we get ...

At the CTO West Coast conference, experts discussed the future of oncology clinical trials and key themes surrounding them.

Learn more about the generative AI technology that will be used at the Food and Drug Administration (FDA) to speed up reviews ...

The Food and Drug Administration has gone all in on AI since Martin Makary, M.D., took over the agency, most recently ...